It is clear since many years that the liability to develop inflammator
y bowel disease is influenced by genetic factors. Recent progresses in
the field of genetic markers and genetic models bring the concept of
genetic heterogeneity. This new concept leads us to try to classify di
fferent forms of inflammatory bowel disease and could have in the futu
re an impact on the prevention, the follow up and the treatment of the
se diseases